Atopic dermatitis can disrupt sleep, work, and daily life for many adults. New treatments like the JAK inhibitor baricitinib are reshaping care, with clinical trials showing promising results for patients with moderate-to-severe disease.
Log In or Register as a healthcare professional to read the full article.
